CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 85.4% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.

Close

Trade BioNTech BNTX

BioNTech live chart

Instrument Fundamentals

Weekly Search
Weekly
Daily
Date Close Change Change (%) Open High Low

News

Webhose 2026 Aug 28, 05:07

The Bull Case For Pfizer (PFE) Could Change Following New COVID And Lyme Vaccine Milestones - Learn Why

BioNTech SE
Webhose 2026 Aug 27, 23:54

FDA approves updated Covid-19 vaccines

BioNTech SE
Webhose 2026 Aug 27, 21:57

FDA Approves Seasonal Covid-19 Vaccines From Moderna, Pfizer, BioNTech | Morningstar

BioNTech SE
Webhose 2026 Aug 27, 21:52

BioNTech (BNTX) Rallied on Moderna's Win. Does a Competitor's Success Validate its Oncology Pipeline?

BioNTech SE
Webhose 2026 Aug 26, 15:25

Moderna Drops 7% Despite a Fresh Wolfe Research Upgrade, BioNTech Slips

BioNTech SE
Webhose 2026 Aug 26, 13:44

$7+ Billion mRNA Vaccines Market Outlook, 2035: Opportunities, Strategies, Challenges

BioNTech SE
Webhose 2026 Aug 25, 14:24

Moderna Rallies 11%, BioNTech Ticks Up: Is the mRNA Trade Down to One Name?

BioNTech SE
Webhose 2026 Aug 25, 11:15

Cancer Vaccine Breakthrough Lifts 5 Biotech Names. Here's Who's Best Positioned.

BioNTech SE
Webhose 2026 Aug 24, 15:34

Moderna Sinks 7% as Traders Book Profits on a 392% Year-to-Date Surge; BioNTech Drops 4%, Merck Slips

BioNTech SE
Webhose 2026 Aug 24, 14:11

BioNTech Moved Higher as the Broader Biotech Sector Hit a Post-Pandemic Peak, but BNTX Stock Needs Stronger Fundamentals to Keep Climbing

BioNTech SE
Webhose 2026 Aug 23, 05:10

BioNTech (BNTX) Is Up 25.2% After First-in-Class Pumitamig Plus B7H3 ADC Lung Data - What's Changed

BioNTech SE
Webhose 2026 Aug 22, 18:09

BioNTech (BNTX) Stock Looks Fully Priced As It Rebounds From A 67% Fall

BioNTech SE
Webhose 2026 Aug 22, 16:08

BioNTech (BNTX) Presents New Lung Cancer Data, Is The Stock Already Fully Valued?

BioNTech SE
Webhose 2026 Aug 21, 14:06

Moderna Rallies 8%, BioNTech Climbs 4% as the mRNA Trade Whipsaws for a Third Session

BioNTech SE
Webhose 2026 Aug 21, 11:03

BioNTech (NASDAQ:BNTX) Shares Up 7.4% - Here's What Happened - Daily Political

BioNTech SE
Webhose 2026 Aug 20, 15:23

Moderna Sinks 18% After 177% Cancer Vaccine Rally, BioNTech Falls 4%, Merck Slips

BioNTech SE
Webhose 2026 Aug 20, 08:24

Flossbach Von Storch SE Makes New Investment in BioNTech SE Sponsored ADR $BNTX

BioNTech SE
Webhose 2026 Aug 19, 16:20

BioNTech Sees Unusually High Options Volume (NASDAQ:BNTX)

BioNTech SE
Webhose 2026 Aug 19, 16:00

BioNTech (NASDAQ:BNTX) Shares Gap Up - Here's Why

BioNTech SE
Webhose 2026 Aug 19, 13:22

Moderna Rockets 93%, Merck Jumps 7% as Melanoma Therapy Meets Primary Goal in Phase 3 Trial

BioNTech SE
Webhose 2026 Aug 19, 09:05

Biotech Stocks To Keep An Eye On - August 19th - Daily Political

BioNTech SE
Webhose 2026 Aug 19, 07:58

BioNTech SE Sponsored ADR (NASDAQ:BNTX) Receives Average Rating of "Moderate Buy" from Brokerages

BioNTech SE
Webhose 2026 Aug 16, 23:58

BioNTech SE Sponsored ADR (NASDAQ:BNTX) Receives $127.81 Average Target Price from Analysts - Daily Political

BioNTech SE
Webhose 2026 Aug 14, 08:59

BioNTech's oncology pivot comes with a new CEO

BioNTech SE
Webhose 2026 Aug 14, 06:29

BioNTech SE Sponsored ADR (NASDAQ:BNTX) Given Average Recommendation of "Moderate Buy" by Brokerages

BioNTech SE
Webhose 2026 Aug 13, 13:50

BioNTech Just Named a New CEO. Here's What Guido Oelkers' Appointment Means for the Stock.

BioNTech SE
Webhose 2026 Aug 11, 12:31

Pfizer Inc. (PFE) vs. BioNTech SE (BNTX): Which Pharma Giant Is Better Positioned for the Post-COVID Era?

BioNTech SE
Webhose 2026 Aug 11, 08:01

Bios Life leaves stealth with $25M and a Tempus alliance for cancer surveillance

BioNTech SE
Webhose 2026 Aug 10, 07:28

Bank of America Corp DE Raises Stake in BioNTech SE Sponsored ADR $BNTX

BioNTech SE
Webhose 2026 Aug 10, 03:12

Wall Street Zen Downgrades BioNTech (NASDAQ:BNTX) to Sell - Stock Observer

BioNTech SE
Webhose 2026 Aug 09, 07:36

Assenagon Asset Management S.A. Makes New $39.38 Million Investment in BioNTech SE Sponsored ADR $BNTX

BioNTech SE
Webhose 2026 Aug 08, 08:57

Citigroup Cuts BioNTech (NASDAQ:BNTX) Price Target to $125.00

BioNTech SE
Webhose 2026 Aug 08, 07:22

Bank of New York Mellon Corp Trims Stock Position in BioNTech SE Sponsored ADR $BNTX

BioNTech SE
Webhose 2026 Aug 08, 05:30

BioNTech (NASDAQ:BNTX) Rating Lowered to Sell at Wall Street Zen

BioNTech SE
Webhose 2026 Aug 05, 01:47

BioNTech SE Q2 Loss Rises

BioNTech SE
Webhose 2026 Aug 04, 22:47

BioNTech deep in the red as demand for vaccines falls

BioNTech SE
Webhose 2026 Aug 04, 19:56

BioNTech's Promising Oncology Pipeline Is Now in Late-Stage Development | Morningstar

BioNTech SE
Webhose 2026 Aug 04, 14:04

BioNTech Q2 Earnings Call Highlights

BioNTech SE
Webhose 2026 Aug 04, 12:44

BioNTech Q2 Net Loss Widens, Lowers FY26 Revenue Outlook; Stock Falls In Pre-Market

BioNTech SE
Webhose 2026 Aug 04, 12:08

BioNTech Cuts 2026 Sales Forecast Amid Declining COVID Vaccine Demand, ETPharma

BioNTech SE
Webhose 2026 Aug 04, 11:01

BioNTech lowers 2026 sales outlook as COVID vaccine demand softens

BioNTech SE
Webhose 2026 Aug 03, 11:49

BioNTech taps Sobi executive Oelkers as its next CEO

BioNTech SE
Webhose 2026 Aug 03, 09:29

BioNTech says Sobi's Oelkers will replace Sahin as CEO - AOL

BioNTech SE
Webhose 2026 Jul 30, 12:40

EU greenlights Pfizer and BioNTech's new COVID vaccine

BioNTech SE
Webhose 2026 Jul 29, 21:26

Pfizer, BioNTech Updated Covid Vaccine Gets Europe Approval | Morningstar

BioNTech SE
Webhose 2026 Jul 29, 18:30

European Commission Authorizes Pfizer and BioNTech XFG-adapted COVID-19 Vaccine in the European Union

BioNTech SE

BioNTech news

Latest news

Info

Spread

1.1621

Spread (%)

1.1455 %

Leverage

1:5

Overnight Interest Buy

-0.0597 %

Overnight Interest Sell

-0.0292 %

Currency

USD

Trading Hours

Markets closed

Monday

13:31 - 19:59

Tuesday

13:31-19:59

Wednesday

13:31-19:59

Thursday

13:31-19:59

Friday

13:31-19:59

Analysis and statistics

Open

---

Previous Close

---

52 Week High/Low

--- – ---

Market cap

27984166912

Shares Outstanding

251204366

Earnings Date (Next)

0000-00-00

Div Yield

2022-06-17

Ex-Dividend Date

2022-06-02

Forward annual dividend rate

0

Forward annual dividend yield

0

EPS

-7.83

Learn more about this instrument

BioNTech BioNTech SE
BioNTech SE, together with its subsidiaries, engages in the development and commercialization of immunotherapies in Germany. The company offers BNT162, an mRNA vaccine for the treatment of SARS-CoV-2 virus. It also develops oncology drugs under Phase III clinical trial, including Gotistobart for metastatic non-small cell lung cancer, Pumitamig for small cell lung cancer and advanced/metastatic triple-negative breast cancer, and Trastuzumab pamirtecan for metastatic breast cancer and epirubicin and cyclophosphamide; and drugs under Phase 2/3 clinical trial, such as BNT113 for human papillomavirus and head and neck squamous cell carcinoma, as well as Pumitamig for metastatic colorectal and non-small cell lung cancer. In addition, the company engages in the development of oncology drugs under Phase II clinical trial comprising BNT116 for advance non-small cell lung cancer, BNT326/YL202 for multiple solid tumors and advanced/metastatic breast cancer, Autogene cevumeran for advance colorectal cancer, and Gotistobart for platinum-resistant ovarian cancer, as well as Pumitamig for glioblastoma, hepatocellular carcinoma, malignant pleural mesothelioma, neuroendocrine neoplasms, and metastatic pancreatic ductal adenocarcinoma. Further, it develops BNT166 which is Phase II clinical trial for mpox virus; and infectious diseases drugs under Phase 1/2 clinical trial, which include BNT162 + BNT161 for SARS-CoV-2 and influenza, BNT164 for tuberculosis, BNT165 for malaria, and BNT166 for mpox. The company was incorporated in 2008 and is headquartered in Mainz, Germany.

Related Instruments

Asset
Sell
Buy
Change (%)

Latest Education Articles

Trustpilot